Sander Slootweg on LinkedIn: Forbion raises €1.35 billion across …

Sander Slootweg’s Post ... bringing the total of funds under management to €3 billion. The final close of the Forbion Ventures Fund VI has reached the hard cap amount of €750 million, and ...

CouponFollow Extension

€1.35
OFF

Sander Slootweg On LinkedIn: Forbion Raises €1.35 Billion Across …

2 days from now

Sander Slootweg’s Post ... bringing the total of funds under management to €3 billion. The final close of the Forbion Ventures Fund VI has reached the hard cap amount of €750 million, and ...

linkedin.com

€1.35
OFF

Forbion Raises €1.35 Billion Across Two Funds | Forbion

2 days from now

Apr 19, 2023 · The Forbion Growth Opportunities Fund II has already made four investments to date. Sander Slootweg, Managing Partner and co-founder of Forbion said: “We are extremely …

forbion.com

$1
OFF

Forbion On LinkedIn: Forbion Raises €1.35 Billion Across Two Funds ...

2 days from now

Forbion Company News Update - we are proud to announce that we have raised €1.35 billion ($1.5 billion) for our two newest funds, bringing the total of funds… | 40 comments on LinkedIn

linkedin.com

€1.35
OFF

Dirk Kersten On LinkedIn: Forbion Raises €1.35 Billion Across Two …

2 days from now

Excited to share the news that we at Forbion raised two new funds allowing us to keep supporting Biotech entrepreneurs and jointly focus on getting new therapies to patients faster.

linkedin.com

€2
OFF

Investors In Healthcare On LinkedIn: The Netherlands: Forbion …

2 days from now

Forbion raises over €2bn across two newest funds #VC #lifesciences Sander Slootweg https://lnkd.in/eVXi8gGM Investors in Healthcare on LinkedIn: The Netherlands: Forbion raises …

linkedin.com

€1.35
OFF

Dirk Kersten On LinkedIn: Forbion Raises €1.35 Billion Across Two …

2 days from now

Excited to share the news that we at Forbion raised two new funds allowing us to keep supporting Biotech entrepreneurs and jointly focus on getting new… Dirk Kersten on LinkedIn: Forbion …

linkedin.com

€1
OFF

Interview: Investors In Healthcare Meets Forbion Co-founder And ...

2 days from now

Sep 3, 2021 · Sander Slootweg, managing partner and co-founder of Forbion Forbion, one of Europe’s leading venture capital firms, currently manages over €1.8bn from nine closed-end …

investorsinhealthcare.com

FAQs about Sander Slootweg on LinkedIn: Forbion raises €1.35 billion across … Coupon?

How much did forbion raise in 2023?

Naarden, The Netherlands and Munich, Germany – 19 April, 2023 – Forbion, a leading European life sciences venture capital firm, today announces that it has raised €1.35 billion ($1.5 billion) for its two newest funds, bringing the total of funds under management to €3 billion. ...

Who manages the forbion Ventures Fund VI & Growth Opportunities Fund II?

The Forbion Ventures Fund VI and the Forbion Growth Opportunities Fund II will be managed by Forbion’s highly specialized and experienced investment team and supported by a high-caliber group of Operating Partners, Venture Partners and Advisers. - ENDS - For more information, please contact: Notes for Editors: ...

How many companies will the forbion growth opportunities fund invest in?

It is anticipated that the Forbion Growth Opportunities Fund III and Forbion Ventures Fund VII will each invest in approximately 15 portfolio companies. ...

How much money has forbion raised?

Both funds exceeded their original target sizes and represent Forbion’s largest fundraising success to date. The final close of the Forbion Ventures Fund VI has reached the hard cap amount of €750 million and the final close of the Forbion Growth Opportunities Fund II has also been secured at the hard cap amount of €600 million. ...

What is the forbion Growth Opportunities Fund II?

The Forbion Growth Opportunities Fund II builds on the strength of Forbion’s first Growth Fund. The fund is focused on investing primarily in European later-stage biopharma companies developing novel therapies in areas of high medical need. ...

What is the forbion Ventures Fund?

The Forbion Ventures Fund VI is focused on building companies at an earlier stage of development and the Forbion Growth Opportunities Fund II supports the expansion of late-stage life sciences companies. ...